(Q33160416)

23 July 2017

0 references

1 reference

title

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments (English)

1 reference

catecholaminergic polymorphic ventricular tachycardia

23 July 2017

0 references

0 references

ventricular tachycardia

1 reference

3

Arthur A M Wilde

1 reference

23 July 2017

2

Aeilko H Zwinderman

1 reference

23 July 2017

author name string

Christian van der Werf

series ordinal

1

1 reference

23 July 2017

language of work or name

1 reference

4 September 2011

1 reference

23 July 2017

1 reference

23 July 2017

volume

14

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

175-183

1 reference

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Paroxysmal Tachycardia with Episodic Unconsciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Bidirectional tachycardia in a child. A study using His bundle electrography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Clinical spectrum and prognostic factors of pediatric ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

21 January 2018

L-type calcium channels

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Prevention of Ventricular Arrhythmia and Calcium Dysregulation in a Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model Carrying Calsequestrin-2 Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Successful treatment of catecholaminergic polymorphic ventricular tachycardia with bilateral thoracoscopic sympathectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Risks and challenges of implantable cardioverter-defibrillators in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Adenosine triphosphate terminates bidirectional ventricular tachycardia in a patient with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR277

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUR277

1 reference

23 July 2017

1 reference